Trial no.:
|
PACTR202508908830998 |
Date of Registration:
|
07/08/2025 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
YAG Laser Peripheral Iridotomy in Primary Angle Closure |
Official scientific title |
Impact of YAG Laser Peripheral Iridotomy on Anterior Segment in Primary Angle Closure using Optical Coherence Tomography and Corneal Tomography |
Brief summary describing the background
and objectives of the trial
|
Glaucoma is a major cause of irreversible blindness worldwide, with primary angle closure glaucoma (PACG) accounting for 25% of all kinds of glaucoma globally. The angle closure spectrum includes three stages; primary angle-closure suspects (PACS), primary angle closure (PAC), and primary angle closure glaucoma (PACG). Several studies have proven that patients with PACS as well as PAC can benefit from laser peripheral iridotomy (LPI) in relieving pupillary block, widening the AC angle, and decreasing the risk of progression into PACG.
Gonioscopy is the golden standard for angle examination in those patients, however has some disadvantages, which may significantly affect the precise record of angle width; including patient’s eye contact and use of light that may affect the angle opening. In addition, the procedure can take years to master, and can be subjective with no agreement between the examiners .
The introduction of new imaging modalities such as corneal tomography and anterior segment optical coherence tomography (AS-OCT) can have some advantages over gonioscopy such as providing accurate, reliable and reproducible measurement of different AC parameters, requiring no contact with the eye and the ability to be done in complete darkness or under standardized lighting conditions.
Aim of the work: To evaluate changes in anterior segment parameters before and after LPI in patients with PACS and PAC using AS-OCT and corneal tomography.
Objectives:
1) Measure and compare changes in AC parameters in patients with PACS and PAC before, one month and 3 months after LPI using both AS-OCT and corneal tomography.
2) Correlate between the AC parameters measured by AS-OCT, corneal tomography and gonioscopy.
3) Report changes in intraocular pressure at one month and 3 months after LPI in patients with PACS and PAC.
4) Report any complications related to the intervention.
|
Type of trial |
Non-Randomised |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Eye Diseases |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Diagnosis / Prognosis |
Anticipated trial start date |
04/08/2024 |
Actual trial start date |
06/08/2024 |
Anticipated date of last follow up |
09/08/2025 |
Actual Last follow-up date |
09/08/2025 |
Anticipated target sample size (number of participants) |
30 |
Actual target sample size (number of participants) |
|
Recruitment status |
Closed to recruitment,follow-up continuing |
Publication URL |
|
|